Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.79 -0.05 (-2.45%)
As of: Sep 29, 2026 · 3:57 PM EDT

Processa Pharmaceuticals (PCSA) Share-based Compensation (2012 - 2026)

Updated

Processa Pharmaceuticals (PCSA) recorded Share-based Compensation of $92,105 in Q2 2026, down 54.7% from $203,251 a year earlier and down 4.0% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Share-based Compensation (2012 - 2026) Analysis & Trends

On a TTM basis, Processa Pharmaceuticals' Share-based Compensation came in at $614,656 as of Jun 30, 2026, down 17.0% year-over-year; for FY2025, it was $857,550, up 36.2% from FY2024.

  • Annual Share-based Compensation has a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $629,514 in FY2024 (-52.0%), $1.31 million in FY2023 (-85.2%), $8.83 million in FY2022 (+159.1%) and $3.41 million in FY2021 (+24.8%).
  • The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q2 2019.
  • On a year-over-year basis, Share-based Compensation has declined for three consecutive quarters, with growth averaging 5.8% over the last seven quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 577.3% in Q3 2021, against a decline of 95.6% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $95,963 (Q1 2026), $123,541 (Q4 2025) and $303,047 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Processa Pharmaceuticals 5.14 Mn 5.14 Mn - 92,105.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,105.00
Mar 31, 2026 95,963.00
Dec 31, 2025 123,541.00
Sep 30, 2025 303,047.00
Jun 30, 2025 203,251.00
Mar 31, 2025 227,711.00
Dec 31, 2024 155,048.00
Sep 30, 2024 154,191.00
Jun 30, 2024 152,632.00
Mar 31, 2024 167,643.00
Sep 30, 2023 142,894.00
Jun 30, 2023 319,123.00
Mar 31, 2023 1.31 Mn
Dec 31, 2022 2.78 Mn
Sep 30, 2022 3.21 Mn
Jun 30, 2022 2.01 Mn
Mar 31, 2022 828,897.00
Dec 31, 2021 1.12 Mn
Sep 30, 2021 1.11 Mn
Jun 30, 2021 865,323.00
API Access

Processa Pharmaceuticals Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PCSA&period=max&api_key=YOUR_API_KEY